Company intelligence / Profile preview

Natural Shrimp

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Natural Shrimp has developed the first commercially viable system for growing antibiotic-free, gourmet-grade Pacific white shrimp indoors using patented RAS technology. Their systems have demonstrated effective ammonia removal and increased shrimp growth rates compared to traditional methods, with successful commercial deployments in the US and a validated trial in Japan. The company is expanding its geographic and market footprint, targeting both domestic and international buyers in the gourmet seafood segment.

Therapeutic areas: OtherInfectious Diseases
Modalities: Recirculating Aquaculture SystemElectrocoagulationHydrogas
Industry: Agriculture & AgTech

Partnerships

Hydrenesis (technology partner)Japanese aquaculture research facilityUS Foods (distribution)

Beyond the preview

Go deeper on Natural Shrimp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Shrimp.

Explore the full profile